Comparison of buspirone in two separate studies

Area of Science:

• Psychiatry
• Clinical Psychology
• Pharmacology

Background:

• Anxiety disorders are prevalent, often co-occurring with depression.
• Benzodiazepines are commonly prescribed but associated with side effects like sedation.
• Novel anxiolytic agents are sought to improve treatment efficacy and tolerability.

Purpose of the Study:

• To evaluate the efficacy and safety of buspirone in treating moderate to severe anxiety in outpatients.
• To compare buspirone's effects against placebo, diazepam, and clorazepate.

Main Methods:

• Two double-blind, randomized controlled trials (Study A and Study B).
• Participants: Outpatients diagnosed with moderate to severe anxiety.
• Assessments: Hamilton Rating Scales for Depression and Anxiety, SCL-56, Profile of Mood States (POMS), Covi and Raskin scales.

Main Results:

• Buspirone demonstrated consistent relief of both anxiety and associated depressive symptoms.
• Study B showed trends favoring buspirone on several SCL-56 items and the Hamilton somatic factor.
• Significant improvements were noted for several POMS items with buspirone treatment.
• Buspirone was associated with significantly less sedation compared to diazepam and clorazepate.

Conclusions:

• Buspirone is an effective treatment for anxiety and comorbid depression in outpatients.
• Buspirone offers a favorable side effect profile, particularly regarding sedation, compared to traditional benzodiazepines.
• Buspirone represents a valuable therapeutic option for managing anxiety disorders.